Head of Marketing Communications
Apollo.ioFull Time
Senior (5 to 8 years)
Join one of the most exciting companies in health: Virta Health is on a mission to reverse type 2 diabetes and obesity in 1 billion people. We’re pioneering a nutrition-first, tech-enabled approach to chronic disease reversal. At a time when metabolic health is going mainstream from the rise of GLP-1s, the diabetes and obesity crises, and bipartisan initiatives on nutrition and longevity, Virta is leading with a clinically proven, cost-saving approach that’s been changing lives for a decade.
We’re backed by $350M+ from top-tier investors, and cover over 12 million lives through leading health plans, employers, and government partnerships. Virta has earned top honors on the CNBC Disruptor List, Time’s Most Influential Companies, and Inc.’s Best Place to Work, and we’re just getting started.
Following a record-setting year, we’re focused on scaling with intention and building the foundation for long-term, large-scale impact. We’re now seeking a Director of Corporate Communications to own and build a bold, modern media engine. This is a career-making opportunity for a natural storyteller ready to shape our public narrative, amplify our growth, and drive our message across an increasingly fragmented and fast-evolving media landscape.
This is an opportunity to:
Your first 90 days won’t be about observation, they’ll be about action. You’ll hit the ground running, making an immediate impact as you build the foundation for Virta’s next chapter.
Reverses type 2 diabetes through personalized care
Virta Health focuses on reversing type 2 diabetes through a combination of personalized nutrition, continuous remote care, and behavioral science. Their treatment is designed for individuals diagnosed with type 2 diabetes, healthcare providers, and enterprise partners like employers and health plans. Unlike many competitors, Virta Health operates on a performance-based model, meaning they only receive payment if they achieve successful outcomes for their patients. This aligns their financial incentives with patient health improvements. The company's goal is to reverse type 2 diabetes in 100 million people, making their approach not just about managing diabetes but actively working towards its reversal.